Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EC Healthcare ( (HK:2138) ) has issued an update.
EC Healthcare has announced that its board of directors will meet on 28 November 2025 to consider and approve the interim results for the six months ending 30 September 2025. The board will also discuss the potential payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial health and potential returns for stakeholders.
The most recent analyst rating on (HK:2138) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on EC Healthcare stock, see the HK:2138 Stock Forecast page.
More about EC Healthcare
EC Healthcare is a company incorporated in the Cayman Islands, operating in the healthcare industry. It is listed on the Hong Kong Stock Exchange and provides a range of healthcare services.
Average Trading Volume: 1,445,399
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$770.4M
For detailed information about 2138 stock, go to TipRanks’ Stock Analysis page.